Hoffmann-La Roche

Genomics Global Market - Forecast to 2027

Wednesday, November 25, 2020 - 3:30pm

According to the analysis, the genomics global market is expected to reach $31,835.9 million by 2027 growing at a mid single digit CAGR from 2020 to 2027.

Key Points: 
  • According to the analysis, the genomics global market is expected to reach $31,835.9 million by 2027 growing at a mid single digit CAGR from 2020 to 2027.
  • Asia-Pacific is fastest growing region in Genomics market and is expected to grow double digit CAGR from 2020 to 2027.
  • The Genomics market is consolidated with the 6 top players occupying xx% of the market share and the remaining xx% of the market is occupied by other players and service providers.
  • The key players in Genomics Global Market include F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Netherlands), Danaher Corporation.

Diagnostic Capabilities Remain of Utmost Importance as Cases Surge Worldwide

Wednesday, November 25, 2020 - 2:00pm

Whatever the case, continuous testing on a mass scale remains a crucial component in the fight against the pandemic.

Key Points: 
  • Whatever the case, continuous testing on a mass scale remains a crucial component in the fight against the pandemic.
  • With a negative result in hand, travelers will be exempt from the state's two-week quarantine requirements for new arrivals.
  • An international shortage of lab consumables has emerged as the key rate limiting steps for laboratories to increase their PCR testing capacity worldwide.
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

Diagnostic Capabilities Remain of Utmost Importance as Cases Surge Worldwide

Wednesday, November 25, 2020 - 2:00pm

Whatever the case, continuous testing on a mass scale remains a crucial component in the fight against the pandemic.

Key Points: 
  • Whatever the case, continuous testing on a mass scale remains a crucial component in the fight against the pandemic.
  • With a negative result in hand, travelers will be exempt from the state's two-week quarantine requirements for new arrivals.
  • An international shortage of lab consumables has emerged as the key rate limiting steps for laboratories to increase their PCR testing capacity worldwide.
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

Global PCR & Real-time PCR Molecular Diagnostics Market (2020 to 2030) - Industry Analysis, Size, Share, Growth, Trends, and Forecast

Wednesday, November 25, 2020 - 1:00pm

What is the market position of different companies operating in the global PCR & real-time PCR molecular diagnostics market?

Key Points: 
  • What is the market position of different companies operating in the global PCR & real-time PCR molecular diagnostics market?
  • It is followed by market introduction, market dynamics, and an overview of the global PCR & real-time PCR molecular diagnostics market, which includes analysis of market drivers, restraints, and trends pertaining to the global PCR & real-time PCR molecular diagnostics market.
  • The report segments the global PCR & real-time PCR molecular diagnostics market in terms of technology, product, application, end user, and region.
  • Such valuable insights enable market stakeholders in making informed business decisions for investments in the global PCR & real-time PCR molecular diagnostics market.

Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR Testing

Tuesday, November 24, 2020 - 2:00pm

Concurrent with this announcement, the Company announced that it has secured a proprietary supply chain for the most in-demand lab consumable products required to conduct PCR testing.

Key Points: 
  • Concurrent with this announcement, the Company announced that it has secured a proprietary supply chain for the most in-demand lab consumable products required to conduct PCR testing.
  • An international shortage of lab consumables has emerged as the key rate limiting steps for laboratories to increase their PCR testing capacity worldwide.
  • We are very excited with the progress we are making in our base PCR lab testing business.
  • For information related to Todos Medicals COVID-19 testing capabilities, please visit www.todoscovid19.com
    For testing and PPE inquiries, please email sales@todosmedical.com.

Howard University Student Pharmacist Presents Critical Research Following the Conclusion of AMCP Foundation and Genentech Internship

Friday, November 20, 2020 - 11:57pm

Now in its seventh year, the AMCP Foundation and Genentech, a member of the Roche Group.

Key Points: 
  • Now in its seventh year, the AMCP Foundation and Genentech, a member of the Roche Group.
  • "Career journeys in managed care launch each summer through AMCP Foundation internships," said Executive Director Paula J. Eichenbrenner, MBA, CAE.
  • AMCP Foundation congratulates Mr. Taylor for completing the 2020 Evidence for Access Summer Internship Program in partnership with Genentech.
  • Established in 1990, the 501(c)3 nonprofit AMCP Foundation is the philanthropic arm of the Academy of Managed Care Pharmacy (AMCP).

SG Blocks to Deliver up to 7,000 COVID-19 PCR Tests Per Shift Leveraging Its State-of-the-Art D-TEC Module Lab Solutions

Thursday, November 19, 2020 - 9:10pm

SG Blocks is an authorized distributor in the USA of OSANG Healthcares high quality 3-gene PCR or molecular test, millions of which have been sold to governments worldwide.

Key Points: 
  • SG Blocks is an authorized distributor in the USA of OSANG Healthcares high quality 3-gene PCR or molecular test, millions of which have been sold to governments worldwide.
  • The partnership also has factory-direct relationships with global suppliers of essential PCR tests, lab equipment and consumables, the cost savings and priority access benefits of which are passed onto SG Blocks customers.
  • SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction.
  • Each project starts with GreenSteel, the structural core and shell of an SG Blocks building, and then customized to client specifications.

The Rising Incidence of Lung Cancer Will Boost the Lung Cancer Liquid Biopsy Market at a CAGR of Over 16% Through 2020-2024 | Technavio

Thursday, November 19, 2020 - 4:15am

Our lung cancer liquid biopsy market report covers the following areas:

Key Points: 
  • Our lung cancer liquid biopsy market report covers the following areas:
    This study identifies growing partnership agreements as one of the prime reasons driving the lung cancer liquid biopsy market growth during the next few years.
  • We provide a detailed analysis of around 25 vendors operating in the lung cancer liquid biopsy market, including some of the vendors such as Biocartis Group NV, Biocept Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Sysmex Corp., Thermo Fisher Scientific Inc., and Trovagene Inc..
  • Backed with competitive intelligence and benchmarking, our research reports on the lung cancer liquid biopsy market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Specific Diagnostics Announces the Appointment of Jeff Holman as VP of Global Marketing

Thursday, November 19, 2020 - 1:30am

MOUNTAIN VIEW, Calif., Nov. 18, 2020 /PRNewswire-PRWeb/ --Specific Diagnostics today announced the appointment of Jeff Holman as Vice President of Global Marketing, as Specific begins its market launch in Europe.

Key Points: 
  • MOUNTAIN VIEW, Calif., Nov. 18, 2020 /PRNewswire-PRWeb/ --Specific Diagnostics today announced the appointment of Jeff Holman as Vice President of Global Marketing, as Specific begins its market launch in Europe.
  • At Roche Diagnostics Mr. Holman led multiple successful system launches into both the pre-clinical and clinical segments, and was the training leader for the Women's Leadership Initiative (WLI).
  • "I am gratified that Jeff has chosen to join Tony's commercial team at Specific," added Paul A. Rhodes, Ph.D., Specific's CEO.
  • "With the Reveal System, Specific Diagnostics' team has developed a truly remarkable product to address global antibiotic resistant infection," said Mr. Holman.

Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay

Wednesday, November 18, 2020 - 1:53pm

The data generated by NLC Pharma in Israel produced 100% sensitivity and 100% specificity in PCR-confirmed positive and negative COVID-19 patient samples.

Key Points: 
  • The data generated by NLC Pharma in Israel produced 100% sensitivity and 100% specificity in PCR-confirmed positive and negative COVID-19 patient samples.
  • Our rapid test, on the other hand, is based on detecting3CL proteaseactivitywhich is present only at the stage when the virus is actively replicating.
  • Our technology is ideally suited for the high sensitivity detection of individuals infected with replicating virus, regardless of symptom status.
  • Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers.